Aristotle Capital Boston, LLC Charles River Laboratories International, Inc. Transaction History

Aristotle Capital Boston, LLC

  • $1.9 Billion
  • Q2 2025

A detailed history of Aristotle Capital Boston, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Aristotle Capital Boston, LLC holds 96,351 shares of CRL stock, worth $16.9 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
96,351
Previous 104,480 7.78%
Holding current value
$16.9 Million
Previous $15.7 Million 7.04%
% of portfolio
0.77%
Previous 0.81%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$99.75 - $151.89 $810,867 - $1.23 Million
-8,129 Reduced 7.78%
96,351 $14.6 Million
Q1 2025

May 15, 2025
SELL
$150.52 - $190.14 $3.87 Million - $4.88 Million
-25,681 Reduced 19.73%
104,480 $15.7 Million
Q4 2024

Feb 14, 2025
SELL
$178.58 - $220.69 $2.6 Million - $3.21 Million
-14,550 Reduced 10.05%
130,161 $24 Million
Q3 2024

Nov 14, 2024
SELL
$187.96 - $245.29 $1.12 Million - $1.47 Million
-5,983 Reduced 3.97%
144,711 $28.5 Million
Q2 2024

Aug 14, 2024
BUY
$206.39 - $268.73 $436,514 - $568,363
2,115 Added 1.42%
150,694 $31.1 Million
Q1 2024

May 15, 2024
SELL
$203.52 - $273.43 $1.04 Million - $1.39 Million
-5,093 Reduced 3.31%
148,579 $40.3 Million
Q4 2023

Feb 14, 2024
SELL
$164.52 - $238.84 $860,768 - $1.25 Million
-5,232 Reduced 3.29%
153,672 $36.3 Million
Q3 2023

Nov 14, 2023
SELL
$194.44 - $217.61 $276,104 - $309,006
-1,420 Reduced 0.89%
158,904 $31.1 Million
Q2 2023

Aug 14, 2023
BUY
$183.71 - $210.25 $660,253 - $755,638
3,594 Added 2.29%
160,324 $33.7 Million
Q1 2023

May 15, 2023
BUY
$191.89 - $259.92 $561,278 - $760,266
2,925 Added 1.9%
156,730 $31.6 Million
Q4 2022

Feb 14, 2023
SELL
$197.11 - $250.07 $858,019 - $1.09 Million
-4,353 Reduced 2.75%
153,805 $33.5 Million
Q3 2022

Nov 14, 2022
SELL
$182.44 - $250.54 $2.84 Million - $3.9 Million
-15,555 Reduced 8.95%
158,158 $31.1 Million
Q2 2022

Aug 15, 2022
BUY
$204.13 - $302.4 $166,161 - $246,153
814 Added 0.47%
173,713 $37.2 Million
Q1 2022

May 16, 2022
SELL
$255.51 - $362.11 $720,793 - $1.02 Million
-2,821 Reduced 1.61%
172,899 $49.1 Million
Q4 2021

Feb 14, 2022
SELL
$351.38 - $448.68 $16.5 Million - $21.1 Million
-46,963 Reduced 21.09%
175,720 $66.2 Million
Q3 2021

Nov 15, 2021
SELL
$372.64 - $458.3 $26.5 Million - $32.6 Million
-71,144 Reduced 24.21%
222,683 $91.9 Million
Q2 2021

Aug 16, 2021
SELL
$294.17 - $371.65 $9.37 Million - $11.8 Million
-31,855 Reduced 9.78%
293,827 $109 Million
Q1 2021

May 17, 2021
SELL
$249.67 - $299.48 $7.51 Million - $9.01 Million
-30,090 Reduced 8.46%
325,682 $94.4 Million
Q4 2020

Feb 22, 2021
BUY
$222.0 - $252.62 $596,736 - $679,042
2,688 Added 0.76%
355,772 $88.9 Million
Q4 2020

Feb 16, 2021
SELL
$222.0 - $252.62 $11.6 Million - $13.2 Million
-52,243 Reduced 12.89%
353,084 $88.2 Million
Q3 2020

Nov 16, 2020
BUY
$175.56 - $226.45 $1.81 Million - $2.33 Million
10,297 Added 2.61%
405,327 $91.8 Million
Q2 2020

Aug 14, 2020
BUY
$118.84 - $189.72 $4.16 Million - $6.64 Million
34,978 Added 9.71%
395,030 $68.9 Million
Q1 2020

May 15, 2020
SELL
$98.9 - $178.34 $1.61 Million - $2.9 Million
-16,262 Reduced 4.32%
360,052 $45.4 Million
Q4 2019

Feb 14, 2020
BUY
$126.05 - $152.76 $1.01 Million - $1.23 Million
8,032 Added 2.18%
376,314 $57.5 Million
Q3 2019

Nov 14, 2019
BUY
$125.07 - $143.67 $904,506 - $1.04 Million
7,232 Added 2.0%
368,282 $48.7 Million
Q2 2019

Mar 04, 2020
BUY
$123.4 - $148.55 $18.4 Million - $22.2 Million
149,296 Added 70.5%
361,050 $51.2 Million
Q2 2019

Aug 14, 2019
SELL
$123.4 - $148.55 $16.8 Million - $20.3 Million
-136,443 Reduced 39.19%
211,754 $30 Million
Q1 2019

Mar 04, 2020
BUY
$104.82 - $146.73 $15.3 Million - $21.4 Million
146,115 Added 72.3%
348,197 $50.6 Million
Q1 2019

May 15, 2019
BUY
$104.82 - $146.73 $6.06 Million - $8.49 Million
57,859 Added 40.12%
202,082 $29.4 Million
Q4 2018

Feb 13, 2019
BUY
$105.09 - $137.23 $1.92 Million - $2.51 Million
18,271 Added 14.51%
144,223 $16.3 Million
Q3 2018

Sep 16, 2019
BUY
$112.11 - $134.54 $31,502 - $37,805
281 Added 0.22%
125,952 $16.9 Million
Q3 2018

Nov 14, 2018
BUY
$112.11 - $134.54 $591,043 - $709,294
5,272 Added 4.38%
125,671 $16.9 Million
Q2 2018

Aug 13, 2018
SELL
$102.37 - $117.25 $12.8 Million - $14.7 Million
-125,460 Reduced 51.03%
120,399 $13.5 Million
Q1 2018

May 15, 2018
BUY
$98.19 - $115.2 $10.1 Million - $11.9 Million
102,998 Added 72.1%
245,859 $26.2 Million
Q4 2017

Feb 14, 2018
BUY
$100.43 - $118.09 $3.29 Million - $3.87 Million
32,747 Added 29.74%
142,861 $15.6 Million
Q3 2017

Nov 14, 2017
BUY
$96.72 - $109.26 $10.7 Million - $12 Million
110,114
110,114 $11.9 Million

Others Institutions Holding CRL

# of Institutions
615
Shares Held
53.2M
Call Options Held
1.42M
Put Options Held
1.42M
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.92B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Aristotle Capital Boston, LLC Portfolio

Follow Aristotle Capital Boston, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Capital Boston, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Capital Boston, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email